Literature DB >> 25085281

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.

Bradford L Therrell1, Michele A Lloyd-Puryear2, Kathryn M Camp3, Marie Y Mann4.   

Abstract

Inborn errors of metabolism (IEM) are genetic disorders in which specific enzyme defects interfere with the normal metabolism of exogenous (dietary) or endogenous protein, carbohydrate, or fat. In the U.S., many IEM are detected through state newborn screening (NBS) programs. To inform research on IEM and provide necessary resources for researchers, we are providing: tabulation of ten-year state NBS data for selected IEM detected through NBS; costs of medical foods used in the management of IEM; and an assessment of corporate policies regarding provision of nutritional interventions at no or reduced cost to individuals with IEM. The calculated IEM incidences are based on analyses of ten-year data (2001-2011) from the National Newborn Screening Information System (NNSIS). Costs to feed an average person with an IEM were approximated by determining costs to feed an individual with an IEM, minus the annual expenditure for food for an individual without an IEM. Both the incidence and costs of nutritional intervention data will be useful in future research concerning the impact of IEM disorders on families, individuals and society.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Costs; Inborn errors of metabolism; Incidence; Medical foods; Newborn screening; Nutrition

Mesh:

Year:  2014        PMID: 25085281      PMCID: PMC4177968          DOI: 10.1016/j.ymgme.2014.07.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  22 in total

1.  The regional genetic and newborn screening service collaboratives: the first two years.

Authors:  Michele Puryear; Gloria Weissman; Michael Watson; Marie Mann; Bonnie Strickland; Peter C van Dyck
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

2.  National evaluation of US newborn screening system components.

Authors:  Bradford L Therrell; W Harry Hannon
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

3.  Financing state newborn screening programs: sources and uses of funds.

Authors:  Kay Johnson; Michele A Lloyd-Puryear; Marie Y Mann; Lauren Raskin Ramos; Bradford L Therrell
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

4.  Financing newborn screening: sources, issues, and future considerations.

Authors:  Bradford L Therrell; Donna Williams; Kay Johnson; Michele A Lloyd-Puryear; Marie Y Mann; Lauren Raskin Ramos
Journal:  J Public Health Manag Pract       Date:  2007 Mar-Apr

5.  Comprehensive cost-utility analysis of newborn screening strategies.

Authors:  Aaron E Carroll; Stephen M Downs
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study.

Authors:  P Burgard; F Rey; A Rupp; V Abadie; J Rey
Journal:  Pediatr Res       Date:  1997-03       Impact factor: 3.756

7.  Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.

Authors:  Laura N Venditti; Charles P Venditti; Gerard T Berry; Paige B Kaplan; Edward M Kaye; Henry Glick; Charles A Stanley
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

8.  Phenylalanine hydroxylase deficiency: diagnosis and management guideline.

Authors:  Jerry Vockley; Hans C Andersson; Kevin M Antshel; Nancy E Braverman; Barbara K Burton; Dianne M Frazier; John Mitchell; Wendy E Smith; Barry H Thompson; Susan A Berry
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

9.  Newborn screening: toward a uniform screening panel and system.

Authors: 
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

10.  Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.

Authors:  Johannes Pfeil; Stefan Listl; Georg F Hoffmann; Stefan Kölker; Martin Lindner; Peter Burgard
Journal:  Orphanet J Rare Dis       Date:  2013-10-17       Impact factor: 4.123

View more
  33 in total

1.  Anaplerotic therapy in propionic acidemia.

Authors:  Nicola Longo; Leisa B Price; Eduard Gappmaier; Nancy L Cantor; Sharon L Ernst; Carrie Bailey; Marzia Pasquali
Journal:  Mol Genet Metab       Date:  2017-07-12       Impact factor: 4.797

Review 2.  Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.

Authors:  Richard S Olney; Elizabeth C Ailes; Marci K Sontag
Journal:  Semin Perinatol       Date:  2015-04       Impact factor: 3.300

3.  Functional and molecular studies in primary carnitine deficiency.

Authors:  Marta Frigeni; Bijina Balakrishnan; Xue Yin; Fernanda R O Calderon; Rong Mao; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2017-09-14       Impact factor: 4.878

Review 4.  Emerging Concepts in Nutrient Needs.

Authors:  Patrick J Stover; Cutberto Garza; Jane Durga; Martha S Field
Journal:  J Nutr       Date:  2020-10-01       Impact factor: 4.798

5.  Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.

Authors:  Sara Tucci; Ulrich Floegel; Frauke Beermann; Sidney Behringer; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

Review 6.  Carnitine transport and fatty acid oxidation.

Authors:  Nicola Longo; Marta Frigeni; Marzia Pasquali
Journal:  Biochim Biophys Acta       Date:  2016-01-29

7.  Inborn Errors of Metabolism in the United Arab Emirates: Disorders Detected by Newborn Screening (2011-2014).

Authors:  Fatma A Al-Jasmi; Aisha Al-Shamsi; Jozef L Hertecant; Sania M Al-Hamad; Abdul-Kader Souid
Journal:  JIMD Rep       Date:  2015-11-21

8.  Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marzia Pasquali; Chunli Yu; Bradford Coffee
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

9.  Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  A Manta; S Spendiff; H Lochmüller; R Thompson
Journal:  J Neuromuscul Dis       Date:  2021

10.  Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation.

Authors:  Michael Jakoby; Amruta Jaju; Aundrea Marsh; Andrew Wilber
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.